Dan Gebremedhin M.D.

Dan Gebremedhin MD, MBA, is a seasoned partner at Flare Capital Partners, focusing on supporting innovative healthcare technology companies since April 2015. Currently serving as a board member for several organizations including Vita Health, Positive Development, Somatus, Oui Therapeutics, and Eden Health, Dan is dedicated to enhancing patient care through evidence-based interventions and value-based solutions. Leadership roles also include board observer positions at Elektra Health and Aetion, where Dan contributes to advancing healthcare delivery and analytics. Academic credentials include an MBA from Harvard Business School and an MD from Morehouse School of Medicine, complemented by a BS in Biology from UC San Diego.